Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-007636
Filing Date
2022-02-07
Accepted
2022-02-07 21:36:59
Documents
1
Period of Report
2022-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3399
  Complete submission text file 0001209191-22-007636.txt   4854
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
InCube Labs, L.L.C. (Reporting) CIK: 0001873082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40672 | Film No.: 22599128